Zepp Health Corporation (ZEPP)
NYSE: ZEPP · Real-Time Price · USD
4.840
-0.080 (-1.63%)
Sep 9, 2026, 10:26 AM EDT - Market open
Zepp Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 276.03 | 258.9 | 182.6 | 352.86 | 613.64 | 983.87 | |
Revenue Growth | 38.05% | 41.78% | -48.25% | -42.50% | -37.63% | -0.16% |
Cost of Revenue | 169.52 | 159.71 | 112.37 | 260.5 | 494.78 | 778.34 |
Gross Profit | 106.5 | 99.19 | 70.23 | 92.36 | 118.86 | 205.53 |
Selling, General & Admin | 94.79 | 83.1 | 71.33 | 71.31 | 103.42 | 109.66 |
Research & Development | 46.46 | 45.32 | 46.16 | 51.5 | 77.3 | 81.08 |
Operating Expenses | 141.26 | 128.42 | 117.48 | 122.81 | 180.71 | 190.74 |
Operating Income | -34.75 | -29.23 | -47.25 | -30.45 | -61.86 | 14.79 |
Interest Expense | -6.43 | -5.7 | -5.55 | -6.75 | -8.44 | -7.07 |
Interest & Investment Income | 1.45 | 1.53 | 3.67 | 3.09 | 1.82 | 2.63 |
Earnings From Equity Investments | -2.37 | -2.07 | -4.21 | 1.11 | 2.68 | 6.46 |
Other Non Operating Income (Expenses) | -0.07 | 0.06 | -0.66 | -0.53 | 6.45 | 4.32 |
EBT Excluding Unusual Items | -42.17 | -35.41 | -54 | -33.53 | -59.35 | 21.12 |
Gain (Loss) on Sale of Investments | 1.12 | -2.12 | -8.12 | 0.01 | 6.14 | 2.13 |
Pretax Income | -41.05 | -37.53 | -62.12 | -33.52 | -53.21 | 23.25 |
Income Tax Expense | 2.51 | 2.54 | 13.69 | -2.43 | -9.87 | 1.69 |
Earnings From Continuing Operations | -43.56 | -40.07 | -75.81 | -31.09 | -43.35 | 21.56 |
Minority Interest in Earnings | - | - | 0.08 | 0.07 | 0.1 | 0.13 |
Net Income | -43.56 | -40.07 | -75.73 | -31.02 | -43.24 | 21.69 |
Net Income to Common | -43.56 | -40.07 | -75.73 | -31.02 | -43.24 | 21.69 |
Net Income Growth | - | - | - | - | - | -38.09% |
Shares Outstanding (Basic) | 16 | 16 | 16 | 15 | 15 | 16 |
Shares Outstanding (Diluted) | 16 | 16 | 16 | 15 | 15 | 17 |
Shares Change | -1.04% | -1.72% | 6.47% | -1.28% | -6.84% | 1.54% |
EPS (Basic) | -2.75 | -2.52 | -4.68 | -2.04 | -2.81 | 1.38 |
EPS (Diluted) | -2.79 | -2.56 | -4.68 | -2.08 | -2.88 | 1.31 |
EPS Growth | - | - | - | - | - | -39.27% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -26.21 | -25.8 | 41.01 | -118.32 | -43.84 |
Free Cash Flow Per Share | - | -1.65 | -1.59 | 2.70 | -7.69 | -2.65 |
Gross Margin | 38.58% | 38.31% | 38.46% | 26.17% | 19.37% | 20.89% |
Operating Margin | -12.59% | -11.29% | -25.88% | -8.63% | -10.08% | 1.50% |
Profit Margin | -15.78% | -15.48% | -41.47% | -8.79% | -7.05% | 2.21% |
Free Cash Flow Margin | - | -10.12% | -14.13% | 11.62% | -19.28% | -4.46% |
EBITDA | -30.46 | -24.7 | -42.23 | -22.76 | -53.15 | 22.96 |
EBITDA Margin | -11.03% | -9.54% | -23.13% | -6.45% | -8.66% | 2.33% |
D&A For EBITDA | 4.29 | 4.54 | 5.02 | 7.69 | 8.71 | 8.17 |
EBIT | -34.75 | -29.23 | -47.25 | -30.45 | -61.86 | 14.79 |
EBIT Margin | -12.59% | -11.29% | -25.88% | -8.63% | -10.08% | 1.50% |
Effective Tax Rate | - | - | - | - | - | 7.27% |
Advertising Expenses | - | 27.33 | 21.27 | 13.78 | - | - |